Tovo P A, de Martino M, Gabiano C, Cappello N, D'Elia R, Loy A, Plebani A, Zuccotti G V, Dallacasa P, Ferraris G
Department of Paediatrics, University of Turin, Italy.
Lancet. 1992 May 23;339(8804):1249-53. doi: 10.1016/0140-6736(92)91592-v.
The signs that may arise after perinatal infection with human immunodeficiency virus type 1 (HIV-1) have been classified by the Centers for Disease Control, but the clinical usefulness of the classification system and the prognostic importance of each disease pattern have not been established. We sought to address these issues by analysing data from the Italian Register for HIV infection in children. We studied 1887 children born to HIV-1-seropositive mothers. 1045 were identified at birth and the others were registered later (median age 4.8 [range 0.4-72] months). HIV-1-associated signs developed in 433 (81.8%) of 529 seropositive infected children at a median age of 5 (0.03-84) months. These signs appeared significantly earlier in the 102 children who died of HIV-1-related illness than in those who are still alive (median 3 [0.03-55] vs 6 [0.03-84] months; p less than 0.001). The cumulative proportion surviving at age 9 years was 49.5% (95% confidence interval 27-65%) and the median survival time was 96.2 months. Separate analysis of the 112 seropositive infected children followed from birth and older than 15 months gave similar results. Hepatomegaly, splenomegaly, lymphadenopathy, parotitis, skin diseases, and recurrent respiratory tract infections formed the mildest disease pattern. Lymphoid interstitial pneumonitis and thrombocytopenia were signs of intermediate disease. By contrast, in multivariate analysis specific secondary infectious diseases, severe bacterial infections, progressive neurological disease, anaemia, and fever were significant and independent negative predictors of survival. Growth failure, persistent oral candidosis, hepatitis, and cardiopathy were associated in univariate analysis with significantly shorter survival. Our findings suggest that the outlook for children with perinatal HIV-1 infection is better than previously thought and that a new clinical staging system of single disease patterns is needed.
美国疾病控制中心已对1型人类免疫缺陷病毒(HIV-1)围产期感染后可能出现的体征进行了分类,但该分类系统的临床实用性以及每种疾病模式的预后重要性尚未确定。我们试图通过分析意大利儿童HIV感染登记处的数据来解决这些问题。我们研究了1887名HIV-1血清阳性母亲所生的儿童。其中1045名在出生时被确诊,其他儿童后来登记(中位年龄4.8[范围0.4 - 72]个月)。529名血清阳性感染儿童中有433名(81.8%)出现了与HIV-1相关的体征,中位年龄为5(0.03 - 84)个月。这些体征在102名死于HIV-1相关疾病的儿童中出现的时间明显早于仍存活的儿童(中位时间3[0.03 - 55]个月对6[0.03 - 84]个月;p小于0.001)。9岁时的累积存活比例为49.5%(95%置信区间27 - 65%),中位生存时间为96.2个月。对112名从出生起就被跟踪且年龄超过15个月的血清阳性感染儿童进行单独分析,结果相似。肝肿大、脾肿大、淋巴结病、腮腺炎、皮肤病和反复呼吸道感染构成最轻微的疾病模式。淋巴样间质性肺炎和血小板减少是中度疾病的体征。相比之下,在多变量分析中,特定的继发性传染病、严重细菌感染、进行性神经疾病、贫血和发热是生存的显著且独立的负面预测因素。在单变量分析中,生长发育迟缓、持续性口腔念珠菌病、肝炎和心脏病与明显较短的生存期相关。我们的研究结果表明,围产期HIV-1感染儿童的前景比以前认为的要好,并且需要一种新的单一疾病模式的临床分期系统。